Artificial ascites‑assisted microwave ablation for liver cancer adjacent to the diaphragm and perioperative nursing care

Ai,Qinqin; Liu,Delin; Liang,Fei; Kong,Zixiang; Pan,Yanghong; Zhang,Xu

doi:10.3892/ol.2024.14515

Artificial ascites‑assisted microwave ablation for liver cancer adjacent to the diaphragm and perioperative nursing care

Authors:
- Qinqin Ai
- Delin Liu
- Fei Liang
- Zixiang Kong
- Yanghong Pan
- Xu Zhang
View Affiliations

Affiliations: Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang 310006, P.R. China, Department of Ultrasonography, Hangzhou Xixi Hospital, Hangzhou, Zhejiang 310006, P.R. China, Department of Emergency, Hangzhou Xixi Hospital, Hangzhou, Zhejiang 310006, P.R. China, Department of Ultrasonography, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R. China
Published online on: June 18, 2024 https://doi.org/10.3892/ol.2024.14515
Article Number: 382
Copyright: © Ai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cancer near the deep diaphragm can be difficult to visualize due to the effects of lung gas, which presents a challenge for microwave ablation (MWA). The present study aimed to investigate the feasibility and efficacy of artificial ascites‑assisted MWA for treating liver cancer near the deep diaphragm, as well as the significance of perioperative nursing. A retrospective analysis was conducted on patients who underwent artificial ascites‑assisted MWA for liver cancer located near the deep diaphragm between January 2016 and December 2022. Normal saline was utilized as artificial ascites to safeguard the deep diaphragm during MWA. The study recorded the procedural success rate, incidence of major complications, technical efficacy of ablation and local tumor progression (LTP). A total of 62 lesions in 54 patients were included, with 44 men and 10 women, and a mean (± SD) age of 55.64±10.33 years. The ultrasound image quality scores for liver cancer before and after ascites were 3.57±0.79 and 4.89±0.33, respectively, showing a statistically significant difference between the two groups (t=16.324; P<0.05). No diaphragm injury, skin burns at the puncture site or abdominal hemorrhage occurred during the procedure. A single patient developed right‑sided pleural effusion, which did not require drainage. The complete ablation rate was 94.4% (51/54) at 1 month post‑ablation, with 3 patients experiencing recurrence and receiving additional MWA treatment. The median follow‑up time for the patients in this study was 21 months (range, 12‑45 months), with a LTP rate of 5.6% (3/54). In conclusion, MWA assisted by artificial ascites is a safe and effective treatment for liver cancer near the deep diaphragm. Furthermore, perioperative treatment and rehabilitation of the patients with high‑quality nursing is beneficial.

View Figures

View References

1	Fujita M, Yamaguchi R, Hasegawa T, Shimada S, Arihiro K, Hayashi S, Maejima K, Nakano K, Fujimoto A, Ono A, et al: Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations. Ebiomedicine. 53:1026592020. View Article : Google Scholar : PubMed/NCBI
2	Wang SJ, Chao D, Wei W, Nan G, Li JY, Liu FL, Li L, Jiang JL, Cui HY and Chen ZN: CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma. J Exp Clin Cancer Res. 39:1452020. View Article : Google Scholar : PubMed/NCBI
3	Zhang Q, Chen WW, Sun X, Qian D, Tang DD, Zhang LL, Li MY, Wang LY, Wu CJ and Peng W: The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers. Int J Biol Sci. 18:3498–3527. 2022. View Article : Google Scholar : PubMed/NCBI
4	Zhou Z, Li Y, Hao H, Wang Y, Zhou Z, Wang Z and Chu X: Screening hub genes as prognostic biomarkers of hepatocellular carcinoma by bioinformatics analysis. Cell Transplant. 28 (1 Suppl):76S–86S. 2019. View Article : Google Scholar : PubMed/NCBI
5	Meng L, Wei Y and Xiao Y: Chemo-immunoablation of solid tumors: A new concept in tumor ablation. Front Immunol. 13:10575352023. View Article : Google Scholar : PubMed/NCBI
6	Yu J, Cheng ZG, Han ZY, Liu FY, Zheng RQ, Cheng W, Wei Q, Yu SY, Li QY, He GZ, et al: Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: A 12-year real-world, multicentric experience. Liver Cancer. 11:341–353. 2022. View Article : Google Scholar : PubMed/NCBI
7	Ozen M and Raissi D: Editorial comment: A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr. 11:453–456. 2022. View Article : Google Scholar : PubMed/NCBI
8	van de Berg NJ, Meeuwsen FC, Doukas M, Kronreif G, Moelker A and van den Dobbelsteen JJ: Steerable needles for radio-frequency ablation in cirrhotic livers. Sci Rep. 11:3092021. View Article : Google Scholar : PubMed/NCBI
9	Tay BWR, Huang DQ, Mark M, Thong NW, Guan HL, Gee LS, Cheng LH, Mei LY, Thurairajah P, Chen LJ, et al: Comparable outcomes in early hepatocellular carcinomas treated with trans-arterial chemoembolization and radiofrequency ablation. Biomedicines. 10:23612022. View Article : Google Scholar : PubMed/NCBI
10	Li B, Liu C, Xu XX, Li Y, Du Y, Zhang C, Zheng HJ and Yang HF: Clinical application of artificial ascites in assisting CT-guided percutaneous cryoablation of hepatic tumors adjacent to the gastrointestinal tract. Sci Rep. 7:166892017. View Article : Google Scholar : PubMed/NCBI
11	Chu MO, Shen CH, Chang TS, Xu HW, Yen CW, Lu SN and Hung CH: Pretreatment inflammation-based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation. Sci Rep. 8:166112018. View Article : Google Scholar : PubMed/NCBI
12	Yun J, Lee YJ, Kang K and Park J: Effectiveness of SBAR-based simulation programs for nursing students: A systematic review. BMC Med Educ. 23:5072023. View Article : Google Scholar : PubMed/NCBI
13	Fan Z, Zhou P, Jin B, Li G, Feng L, Zhuang C and Wang S: Recent therapeutics in hepatocellular carcinoma. Am J Cancer Res. 13:261–275. 2023.PubMed/NCBI
14	Adnan A, Muñoz NM, Prakash P, Habibollahi P, Cressman ENK and Sheth RA: Hyperthermia and tumor immunity. Cancers (Basel). 13:25072021. View Article : Google Scholar : PubMed/NCBI
15	Huang Q, Li J, Zeng Q, Tan L, Zheng R, He X and Li K: Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery. BMC Cancer. 20:7632020. View Article : Google Scholar : PubMed/NCBI
16	Wang CC and Kao JH: Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma. Hepatol Int. 9:514–519. 2015. View Article : Google Scholar : PubMed/NCBI
17	Nishimura M, Nouso K, Kariyama K, Wakuta A, Kishida M, Wada N, Higashi T and Yamamoto K: Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma. Acta Med Okayama. 66:279–284. 2012.PubMed/NCBI
18	Song SG, Hur YH, Cho JY, Shin MH, Yoon EJ and Kim JW: Pleural effusion after hepatic radiofrequency ablation with artificial ascites: Clinical spectrum and significance. J Vasc Interv Radiol. 31:1636–1644.e1. 2020. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y, Wang J, Li H, Zheng T, Jiang H, Li M and Song B: Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 8:3882020. View Article : Google Scholar : PubMed/NCBI
20	Park SJ, Lee DH and Han JK: Reducing pain by artificial ascites infusion during radiofrequency ablation for subcapsular hepatocellular carcinoma. Cardiovasc Intervent Radiol. 44:565–573. 2021. View Article : Google Scholar : PubMed/NCBI
21	Berghi ON, Dumitru M, Vrinceanu D, Cergan R, Jeican II, Giurcaneanu C and Miron A: Current approach to medico-legal aspects of allergic reactions. Rom J Leg Med. 29:328–331. 2021. View Article : Google Scholar
22	Jiang C, Liu B, Chen S, Peng Z, Xie X and Kuang M: Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging. Int J Hyperthermia. 34:1135–1141. 2018. View Article : Google Scholar : PubMed/NCBI
23	Yuan Y, Li Y, Yang G, Zhang L and Ye J: Effect of Comprehensive nursing approach in perioperative stage of patients with hepatocellular carcinoma interventional therapy. Evid Based Complement Alternat Med. 2022:68624632022. View Article : Google Scholar : PubMed/NCBI
24	Melliza DM and Woodall M: Radiofrequency ablation of liver tumors: The complementary roles of the clinic and research nurse. Gastroenterol Nurs. 23:210–214. 2000. View Article : Google Scholar : PubMed/NCBI
25	Zhang S, Yang Y, Liu W, Yuan B, Tao C and Dou G: Effects of nursing care using a fast-track surgery approach in 49 patients with early-stage hepatocellular carcinoma undergoing first-line treatment with radiofrequency ablation: A retrospective study. Med Sci Monit. 29:e9390442023. View Article : Google Scholar : PubMed/NCBI